| Market Capitalization (Millions $) |
25 |
| Shares
Outstanding (Millions) |
9 |
| Employees |
30 |
| Revenues (TTM) (Millions $) |
2 |
| Net Income (TTM) (Millions $) |
-4 |
| Cash Flow (TTM) (Millions $) |
-3 |
| Capital Exp. (TTM) (Millions $) |
1 |
Dare Bioscience Inc
Dar Bioscience Inc., also known as Dar' Bioscience, is a clinical-stage biopharmaceutical company headquartered in San Diego, California. The company is focused on developing and commercializing innovative products for women's reproductive health. Dar' Bioscience was founded in 2015 and became a public company in 201
The company is led by CEO Sabrina Martucci Johnson, who has more than 20 years of experience in healthcare and biopharmaceutical industries. Johnson is supported by a team of experienced professionals, including researchers, clinical trial specialists, business leaders, and medical doctors.
Dar' Bioscience is developing a portfolio of product candidates designed to address unmet needs in women's reproductive health, including contraception, fertility, and menopause. The company's lead product candidate is Ovaprene, a hormone-free, monthly contraceptive ring designed to prevent pregnancy for up to three months. Ovaprene is currently in Phase 2 clinical trials and has the potential to provide women with a noninvasive and discrete contraceptive option.
In addition to Ovaprene, Dar' Bioscience is also developing other innovative product candidates, including:
- Sildenafil Cream, a topical treatment for female sexual arousal disorder that is currently in Phase 3 clinical trials
- D-Ovulation, a handheld, battery-operated device that tracks ovulation by measuring hormone levels that is currently in Phase 2 clinical trials
- Vaginal tamoxifen, a treatment for vaginal dryness in women with breast cancer that is currently in Phase 1 clinical trials
Dar' Bioscience has a strong intellectual property portfolio that includes multiple patents and patent applications covering its product candidates and technology platforms. The company is also actively pursuing strategic partnerships and collaborations with other companies and organizations to advance its product candidates and bring them to market.
Overall, Dar' Bioscience is a dynamic and innovative biopharmaceutical company that is dedicated to improving women's reproductive health through the development of safe and effective products. With a strong pipeline of product candidates and a committed team of professionals, the company is well positioned to address unmet needs in this important area of healthcare.
Company Address: 3655 Nobel Drive San Diego 92122 CA
Company Phone Number: 926-7655 Stock Exchange / Ticker: DARE
|
0.57% 